Sundew
Sundew is a Danish blue-biotech venture focused on developing and selling biological products that address major problems in aquatic ecosystems. The company uses precision fermentation and engineered biology to create solutions that are designed to be effective, economical, robust, and environmentally benign. Its offerings include natural actives derived from marine organisms and high-performance microalgal delivery systems for RNA and antigens, with a pipeline that targets aquatic pests and diseases, hazardous algal blooms, and aquatic invasive species. Sundew’s first marine natural active, Biokos®, is positioned to control a range of important aquatic fish parasites and is described as easy to use, specific in its effects, and quick to break down in water into edible components. The company says Biokos® is intended to help fish breeders and producers with safe, effective, and environmentally friendly parasite control, and it is offered through Sundew and selected distributors in multiple dosage forms. The team combines entrepreneurship, industrial biotechnology, molecular biology, fermentation science, aquaculture expertise, and commercial experience. Leadership and advisory roles include founders, a CEO/COO/CTO, scientific advisors, and board members with backgrounds spanning biotech startups, scale-up, aquaculture health, and venture investment. Sundew’s mission is to use modern biology to solve important aquatic ecosystem problems and support a more sustainable blue economy.